Apellis Pharmaceuticals, Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:APLS) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities 19.36 M-53.41 M4.45 M108.47 M-14.18 M-60.97 M 37.77 M Cash from investing activities -20 K-8 000-49 K-148 K-108 K-4 000 -309 K Cash from financing activities -4 M274 K6.56 M793 K1.26 M64 K 8.67 M Free cash flow 19.36 M-53.41 M4.4 M108.32 M-14.28 M-60.97 M 37.47 M

News

Stock Market Today: Nasdaq Charges Higher; Hot Nvidia Rival Surges On Debut (Live Coverage)

Compared to Estimates, Apellis Pharmaceuticals (APLS) Q1 Earnings: A Look at Key Metrics

Apellis Pharmaceuticals, Inc. (APLS) Tops Q1 Earnings and Revenue Estimates

Why This Biotech ETF — The IBD Stock Of The Day — Just Reentered Its Buy Zone

Top 3 Health Care Stocks That May Collapse This Month - Apellis Pharmaceuticals (NASDAQ:APLS), Avanos Med

ANI Pharmaceuticals (ANIP) Expected to Beat Earnings Estimates: Should You Buy?

Biogen Beats Q1 Earnings Estimates but Cuts 2026 EPS View on M&A Costs

Apellis Pharmaceuticals, Inc. (APLS) Expected to Beat Earnings Estimates: Should You Buy?

Biogen Walloped Wall Street's First Quarter Views; Here's What Happened

Biogen Q1 Earnings: Can New Launches Offset Declining MS Franchise?

OCGN's Gene-Agnostic Strategy Could Reset Retinal Therapy

OCGN's Gene-Agnostic Strategy Could Reset Retinal Therapy